Anticholinergic burden and revisit risk in frail patients with pharmacological sleepiness.

Jesús Ruiz-RamosLaia López-VinardellLeopoldo Higa-SansoneBerta Torrecilla-Vall-LLosseraMireia Puig-CampmanyMaria Antònia Mangues-BafalluyAna Juanes-Borrego

Published in: European journal of hospital pharmacy : science and practice (2022)

Patients with pharmacological sleepiness and a high anticholinergic burden in their chronic treatment carry a greater risk of revisitation to EDs, and should be considered candidates for specific interventions after visiting these units.

Keyphrases

obstructive sleep apnea
sleep apnea
sleep quality
positive airway pressure
risk factors